INTERNATIONAL JOURNAL OF HYPERTHERMIA

Scope & Guideline

Pioneering research for a healthier tomorrow through hyperthermia.

Introduction

Welcome to the INTERNATIONAL JOURNAL OF HYPERTHERMIA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of INTERNATIONAL JOURNAL OF HYPERTHERMIA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0265-6736
PublisherTAYLOR & FRANCIS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1985 to 2024
AbbreviationINT J HYPERTHER / Int. J. Hyperthermia
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The International Journal of Hyperthermia focuses on the application of hyperthermia in medical treatments, particularly in oncology. The journal encompasses a wide range of research areas related to thermal therapy, emphasizing both clinical and experimental studies that explore the efficacy, safety, and technological advancements in hyperthermia and related ablative techniques.
  1. Thermal Ablation Techniques:
    The journal extensively covers various thermal ablation methods like high-intensity focused ultrasound (HIFU), microwave ablation, and radiofrequency ablation, detailing their efficacy in treating different types of tumors.
  2. Clinical Applications and Outcomes:
    A significant focus on clinical outcomes related to hyperthermia, including studies on patient safety, treatment efficacy, and long-term follow-up results in various cancers, particularly hepatocellular carcinoma and thyroid cancers.
  3. Technological Innovations:
    Research on novel technologies and methodologies for enhancing hyperthermia treatments, including imaging techniques for guidance and monitoring, as well as the development of new devices and protocols.
  4. Mechanistic Studies:
    Investigations into the biological mechanisms underlying the effects of hyperthermia and thermal treatments, including cellular responses, immune responses, and molecular pathways.
  5. Combination Therapies:
    Exploration of the synergistic effects of combining hyperthermia with other treatment modalities such as chemotherapy, radiotherapy, and immunotherapy to improve patient outcomes.
The International Journal of Hyperthermia has seen a significant evolution in its research focus, with emerging themes reflecting the latest advancements and interests in the field of thermal therapies.
  1. Personalized Medicine Approaches:
    An increasing trend towards personalized treatment strategies in hyperthermia, incorporating patient-specific factors and genetic profiles to optimize therapeutic outcomes.
  2. Integration of Imaging Techniques:
    Emerging emphasis on utilizing advanced imaging techniques, such as MRI and ultrasound, for accurate monitoring and guidance during hyperthermia treatments, enhancing precision and safety.
  3. Immunotherapy Synergies:
    A growing body of research exploring the combination of hyperthermia with immunotherapeutic agents, highlighting the potential to enhance immune responses against tumors.
  4. Novel Drug Delivery Systems:
    Investigations into innovative drug delivery systems in conjunction with hyperthermia, such as thermosensitive liposomes or nanoparticles, to improve therapeutic efficacy.
  5. Real-Time Monitoring Technologies:
    Increased focus on the development of real-time monitoring technologies for thermal therapies, allowing for dynamic adjustments during treatment to enhance effectiveness and minimize damage to surrounding tissues.

Declining or Waning

While the journal has consistently focused on the advancements in hyperthermia and related therapies, some areas have seen a decline in frequency of publication, indicating shifting research priorities or saturation of certain topics.
  1. Non-Oncological Applications:
    Research related to non-oncological applications of hyperthermia, such as in rheumatic diseases or other non-cancerous conditions, has been less prominent compared to the emphasis on oncological treatments.
  2. Basic Science Studies:
    There is a noticeable decrease in basic science studies focused on thermal physics or biophysics of hyperthermia, as the journal has shifted towards clinical and translational research.
  3. Longitudinal Studies on Thermal Effects:
    Long-term studies assessing the chronic effects of hyperthermia or thermal damage on tissues have become less frequent, possibly due to a shift towards immediate clinical outcomes.
  4. Historical Reviews and Meta-Analyses:
    The publication of broad historical reviews or comprehensive meta-analyses on previously established techniques is declining, as the journal prioritizes innovative and novel research findings.

Similar Journals

Japanese Journal of Radiology

Empowering Knowledge in Radiology Through Open Access
Publisher: SPRINGERISSN: 1867-1071Frequency: 10 issues/year

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

RADIOTHERAPY AND ONCOLOGY

Transforming cancer therapies with cutting-edge studies and reviews.
Publisher: ELSEVIER IRELAND LTDISSN: 0167-8140Frequency: 12 issues/year

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

PHLEBOLOGY

Elevating clinical insights in the realm of phlebology.
Publisher: SAGE PUBLICATIONS INCISSN: 0268-3555Frequency: 8 issues/year

PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.

Blood Cancer Discovery

Uncovering Breakthroughs in Blood Cancer Science
Publisher: AMER ASSOC CANCER RESEARCHISSN: 2643-3230Frequency: 6 issues/year

Blood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Connecting Research to Real-World Cardiovascular Care
Publisher: WILEYISSN: 1045-3873Frequency: 12 issues/year

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, published by Wiley, stands at the forefront of the fields of Cardiology and Cardiovascular Medicine, boasting an impressive Impact Factor that reflects its scholarly influence. With a strong focus on innovative research, this esteemed journal has been a vital resource for advancing our understanding of electrophysiological concepts since its inception in 1990. As a Q1 journal in both Cardiology and Physiology (medical) as of 2023, it provides a platform for cutting-edge discoveries and comprehensive reviews that cater to the academic and clinical needs of researchers, practitioners, and students alike. The journal features rigorous peer-reviewed articles that delve into various aspects of cardiovascular health, enhancing both theoretical knowledge and clinical application. Although it does not offer open access, it remains a key resource for those engaged in cardiovascular research, published quarterly through 2024 to ensure timely dissemination of high-quality findings.

Cancer Radiotherapie

Advancing cancer care through innovative radiotherapy research.
Publisher: ELSEVIERISSN: 1278-3218Frequency: 6 issues/year

Cancer Radiotherapie, published by Elsevier, is a respected academic journal dedicated to advancing the field of oncology and radiology through original research and comprehensive reviews. With an ISSN of 1278-3218 and an E-ISSN of 1769-6658, the journal serves as a vital platform for disseminating knowledge and innovation in cancer treatment methodologies, specifically focusing on radiotherapy. As of 2023, it holds a Category Quartile of Q3 in both Oncology and Radiology, Nuclear Medicine and Imaging, reflecting its significance within these domains amidst a competitive landscape. Despite its current rankings—205th out of 333 in Radiology and 269th out of 404 in Oncology—it continuously strives to build a reputable presence with contributions that push the boundaries of cancer therapy. Although open access options are not available, the journal is committed to ensuring that valuable insights reach healthcare professionals and researchers worldwide, contributing to improved patient outcomes and advancements in treatment efficacy.

JACC-Clinical Electrophysiology

Connecting Researchers and Clinicians in Electrophysiology
Publisher: ELSEVIERISSN: 2405-500XFrequency: 14 issues/year

JACC-Clinical Electrophysiology, published by Elsevier, stands as a leading journal in the fields of Cardiology and Physiology, with an esteemed Q1 ranking in both categories as of 2023. With an ISSN of 2405-500X and E-ISSN 2405-5018, this journal serves as an essential platform for disseminating cutting-edge research, clinical studies, and innovative practices related to electrophysiological aspects of cardiovascular health. Established in 2015, JACC-Clinical Electrophysiology has attracted high-quality submissions, reflected in its strong presence on Scopus, ranking 41st out of 387 in Cardiology and 15th out of 113 in Physiology (medical), placing it in the 89th and 87th percentiles respectively. Though it operates on a subscription model, its commitment to high standards of peer-reviewed scholarship makes it an indispensable resource for researchers, clinicians, and students dedicated to advancing knowledge and practice in electrophysiology and its impact on cardiac care. Join the community of leaders in the field by engaging with the latest findings and discussions published in this prestigious journal.

Hepatic Oncology

Exploring New Horizons in Liver Cancer Treatment
Publisher: FUTURE MEDICINE LTDISSN: 2045-0923Frequency: 4 issues/year

Hepatic Oncology is a premier Open Access journal published by Future Medicine Ltd that specializes in the critical intersection of hepatology and oncology. With a focus on advancing knowledge in the diagnosis and treatment of liver cancers, the journal provides a platform for innovative research, reviews, and clinical perspectives that serve as a valuable resource for researchers, clinicians, and students alike. Established in 2016 and evolving over the years, Hepatic Oncology underscores its commitment to accessible scientific communication, having transitioned to open access in 2018 to reach a broader audience. The journal holds a Q4 quartile ranking in the fields of hepatology and oncology for 2023, reflecting its emerging influence and role in contemporary research. Through high-quality articles and a focus on real-world applications, Hepatic Oncology aims to bridge gaps in knowledge while fostering collaboration among professionals dedicated to enhancing patient care in hepatic malignancies.

Gynecology and Minimally Invasive Therapy-GMIT

Leading the way in minimally invasive gynecological therapies.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2213-3070Frequency: 4 issues/year

Gynecology and Minimally Invasive Therapy (GMIT) is a distinguished open-access journal published by Wolters Kluwer Medknow Publications, focused on advancing the field of obstetrics and gynecology through innovative research and insights into minimally invasive techniques. With an ISSN of 2213-3070 and E-ISSN 2213-3089, GMIT has established itself as a prominent platform for researchers and clinicians alike, facilitating the dissemination of pivotal findings since its inception in 2012. The journal currently ranks in the Q3 category for Obstetrics and Gynecology in 2023, with a Scopus ranking of #120/209, placing it in the 42nd percentile within its field. Based in Mumbai, India, it has embraced open access since 2016, promoting the wide availability of groundbreaking research to enhance clinical practices and improve patient outcomes. GMIT aims to foster knowledge sharing and interdisciplinary collaboration, vital for professionals in the rapidly evolving landscape of gynecological care.

Iranian Journal of Radiology

Pioneering Knowledge in the Evolving Field of Radiology
Publisher: BRIEFLANDISSN: 1735-1065Frequency: 4 issues/year

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.